Harrow, Inc. (HROW) Year-over-year earnings per share growth for the last twelve months

Harrow Corp (HROW) - corporate logo

Harrow, Inc. (HROW) dominance in the ophthalmology niche and its ownership of a unique innovation portfolio drive the upward trajectory of quarterly EPS growth, where the current value is 868.00. Profit stability is ensured by the localization of production in the US, which mitigates import risks. The company's economic moat is strengthened by an advanced distribution network and surgeon trust, confirming the fundamental trend on this chart.

harrowinc.com (HROW) - Year-over-year earnings per one share growth for the last 12 months from 07/04/2022 to 11/15/2026

harrowinc.com (HROW) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Price harrowinc.com|HROW - Average Forecast Price
- market capitalization details:
Market Value Harrow Inc|HROW - Company Buyout Price
- book capitalization data:
Book Value per Share Harrow|HROW - Accounting Value of Company|Market Capitalization to Book Value Ratio harrowinc.com|HROW - Company Total Assets
- debt level and financial liquidity data:
Debt to Equity Harrow, Inc.|HROW - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Harrow|HROW - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Harrow Health|HROW - Long-Term Debt|Company Current Liabilities Harrow|Quick Liquidity Indicator harrowinc.com
- earnings and valuation multiples indicators:
HROW - Final Profit|Projected Future Earnings Harrow, Inc.|HROW - Business Payback Period|Future Price to Earnings Harrow|HROW - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Harrow, Inc.|HROW - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Harrow|HROW - Net earnings per share for the last four quarters|Quarterly EPS earnings growth harrowinc.com|HROW - Earnings per share increase in current year|Net earnings per share growth forecast for next year Harrow, Inc.
- sales revenue and business income indicators:
HROW - Company Sales Revenue|Company Projected Revenue harrowinc.com|HROW - Price to Sales|Forward Price-to-Revenue Multiple Harrow, Inc.
Summary company analytics:Harrow, Inc.
Manufactured product of Harrow, Inc.

The stable cash flow and customer loyalty of Harrow, Inc. (HROW) are reflected in the quarterly EPS momentum profile. This indicator measures the rate of change in earnings per share, revealing hidden supply-demand imbalances prior to official reports. The calculation is based on a comparison of the current quarterly result with the same period last year. A weakening of this momentum signals that growth drivers are exhausted. It is critical for investors to identify a fading trend to avoid overpaying for the asset.

Analysis of competing companies

Alcon Corp (ALC) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Bausch Health (BLCO)|Year-over-year earnings per share growth for the last twelve months glaukos.com|Apellis Pharmaceuticals (APLS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BLTE|OCUL - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth VRDN (Viridian Corp)|LENZ Corp (LENZ) - Earnings per share growth in annualized terms for the last twelve months|OCS: Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months eyepointpharma.com|KOD: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Aldeyra Therapeutics (ALDX)|Year-over-year net earnings per share growth for the last 12 months KALA|IRD - Net earnings per share growth for the trailing year|Year-over-year earnings per share growth for the last twelve months okyopharma.com (OKYO)|Quarterly EPS earnings growth Adverum Biotechnologies Inc. (ADVM)|Year-over-year earnings per share growth for the last twelve months outlooktherapeutics.com OTLK|Year-over-year net earnings per share change for the last twelve months Clearside Biomedical, Inc. (CLSD)|NBY - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Year-over-year earnings per share growth for the last twelve months|Eyenovia Inc. - Year-over-year earnings per one share growth for the last 12 months|GHSI (Guardion Health Sciences) - Quarterly EPS earnings growth|Ocuphire Pharma - Year-over-year net earnings per share trend for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OPT (Opthea)